IDNAvsIWM
iShares Genomics Immunology and Healthcare ETF against iShares Russell 2000 ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDNA | IWM | |
|---|---|---|
| Expense ratio | 0.47% | 0.19% |
| Assets | $317M | $79.3B |
| Net flow, 1 month | +$49M | +$2.3B |
| Net flow, 1 year | +$106M | −$1.2B |
| Return, YTD | +56.1% | +14.3% |
| Return, 1 year | +66.5% | +14.0% |
| Avg daily volume | 195K | 24.8M |
| Holdings | 63 | 1941 |
| Listed | Jun 11, 2019 | May 22, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS